What to Focus On 1-4

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/13

encourage image

There's no tags or description

Looks like no tags are added yet.

14 Terms

1
New cards

FDA Trials Phase 1

  • 20-80 healthy volunteers to take the drug.

  • Goal: Determine most common side effects, how a drug is metabolized and excreted (ADME/pharmacokinetics), and safety of drug at various doses.

  • Lasts a few days to 1 month


2
New cards

FDA Trials Phase 2

  • 100-300 patients with the disease of interest.

  • Determine short-term efficacy as well as side effects and safety.

  • Lasts a few months to 1 year


3
New cards

FDA Trials Phase 3

  • Done on a large group of participants (1,000-3,000) that have the disease of interest.

  • Determines long-term efficacy as well as safety.

  • Lasts 1-4 years.


4
New cards

FDA Trials Pre-Clinical Phase

  • In vitro studies and animal testing.

  • Determines efficacy, selectivity, mechanism of action after finding a lead compound.

  • Can last 1-4 years.


5
New cards

FDA Trials Phase 4

  • Post-market surveillance of drug (entirety of patient population taking the drug).

  • Long-term safety and side effects as well as effectiveness.

  • Lasts for as long as the drug is on the market.


6
New cards

IND Definition

Investigational New Drug Application


A formal request for U.S. Food and Drug Administration (FDA) authorization to administer an unapproved drug or biological product to humans (happens after pre-clinical trials).

7
New cards

NDA Definition

New Drug Application


Formal request a sponsor submits to get approval to market and sell a new pharmaceutical drug in the US (done after Phase 3 trials).

8
New cards

Drug Shortages information located on FDA website?

  • Manufacturing Problems

  • Quality Issues

  • Raw Material Shortages

  • Discontinuations

  • Natural disasters that interrupt production.


9
New cards

FDA Safety and Innovation Act of 2012

Manufacturers of high-importance drugs must notify the Secretary of the DHHS of a permanent discontinuation in the manufacturing of the drug at least 6 months prior to date of discontinuation.

10
New cards

Drug Labeling Information on FDA Website

3 Sections:

  • Highlights - Contains selected information from the full prescribing details.

  • Table of Contents - Lists sections and subsections of the full prescribing information.

  • Full Prescribing Information - All the information needed for safe and effective use of the drug.


11
New cards

2006 FDA Physician Labeling Rule

Mandated consistent labeling with the goal of making information easier to find on the drug label.

12
New cards

What can be found an FDA label?

Highlights:

  • Black Box Warnings

  • Indications and Usage

  • Dosage and Administration

  • Dosage Forms and Strengths

  • Contraindications

  • Warnings and Precautions

  • Adverse Reactions

  • Drug Interactions

  • Use in Specific Populations

Full:

  • Overdosage

  • Description

  • Clinical Pharmacology/Studies

  • Toxicology

  • Storage and Handling

  • Counseling Information



13
New cards

Label Misc. Notes

•Label is negotiated by manufacturer & FDA

•Includes summaries of studies completed for drug approval

•No references, as publication of studies is not required

•Post-marketing safety studies are incorporated at a later date

14
New cards

What is MedWatch? Who can use it?

MedWatch is an adverse drug event reporting platform on the FDA website. Anyone can use it by filing a 3500 form (A: Health Professionals, B: Consumers/Patients).